AQR Capital Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $158K | Buy |
+20,920
| New | +$158K | ﹤0.01% | 3103 |
|
|
2023
Q4 | – | Sell |
-21,774
| Closed | -$197K | – | 2344 |
|
|
2023
Q3 | $197K | Sell |
21,774
-50,048
| -70% | -$453K | ﹤0.01% | 2146 |
|
|
2023
Q2 | $773K | Sell |
71,822
-16,470
| -19% | -$177K | ﹤0.01% | 1657 |
|
|
2023
Q1 | $903K | Sell |
88,292
-23,068
| -21% | -$236K | ﹤0.01% | 1585 |
|
|
2022
Q4 | $1.17M | Buy |
111,360
+2,958
| +3% | +$31.2K | ﹤0.01% | 1500 |
|
|
2022
Q3 | $1.39M | Buy |
108,402
+87,493
| +418% | +$1.12M | ﹤0.01% | 1366 |
|
|
2022
Q2 | $268K | Buy |
+20,909
| New | +$268K | ﹤0.01% | 1900 |
|